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Abstract
Introduction
Blood lead concentrations among children aged 6 years
and younger become a concern at 10 µg/dL (0.48 µmol/L) or
higher. The authors’ objective was to determine whether
initial blood lead concentrations of 10–19 µg/dL (0.48–0.96
µmol/L) declined among children aged 3 years and younger
and whether the magnitude of decline was associated with
the case management protocol of the state or local child-
hood lead poisoning prevention program.
Methods
The authors analyzed childhood blood lead surveillance
data from 1994 through 1995 and case management pro-
tocols from six states that reported the results of all blood
lead tests. The study included 2109 children aged 2 years
or younger who had a venous blood lead concentration of
10–19 µg/dL (0.48–0.96 µmol/L) and a follow-up venous
blood lead test within 3 to 12 months.
Results
Overall, blood lead concentrations increased by 0.25
µg/dL (0.01 µmol/L) between the time of the initial elevat-
ed blood lead test and the follow-up test, but concentra-
tions declined by 1.96 µg/dL (0.09 µmol/L) among children
covered by a case management protocol that included a
home visit and by 0.92 µg/dL (0.04 µmol/L) among those
covered by a protocol that included a lead source investi-
gation. The decline remained significant after we adjusted
for the child’s age.
Conclusion
These findings suggest that childhood lead prevention
programs should consider focusing their efforts on home
visits and lead source investigations.
Introduction
Children are exposed to lead from multiple sources,
including lead-based paint and lead-contaminated dust.
This exposure can have chronic consequences. Preschool
children with blood lead concentrations greater than 9
µg/dL (0.43 µmol/L) have lower intelligence and more per-
formance problems on average than do children who are
unexposed to lead (1,2). Research by Bellinger et al (1991)
and Ruff et al (1996) suggests that scores for children aged
2 years on measures of cognitive performance drop one
point for every 1-µg/dL (0.05-µmol/L) increase in blood lead
concentration (1,2). Although the decreases in cognitive
performance are small individually, in the aggregate they
may result in more children with behavioral problems and
lower intelligence. Childhood lead exposure can also result
in adult chronic health problems (e.g., adverse pregnancy
outcomes [3,4], hypertension [5,6]).
In 1991, the Centers for Disease Control and Prevention
(CDC) designated blood lead concentrations of 10 µg/dL
(0.48 µmol/L) or higher as the level of concern for children
aged 6 years and younger. Children were not considered to
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need environmental or medical intervention unless their
blood lead concentration was 20 µg/dL (0.97 µmol/L) or
higher (7). An estimated 890,000 children aged 6 years and
younger had blood lead concentrations of 10 µg/dL (0.48
µmol/L) or greater in the United States from 1991 through
1994 (8). Although blood lead concentrations among young
children have declined since 1994, exposure to lead contin-
ues to be a significant problem (9).
Blood lead concentrations of exposed, untreated chil-
dren increase until children are about aged 2 years and
decline thereafter (10). Behavioral and environmental
changes to reduce lead exposure are necessary to lower
blood lead concentrations before children are aged 2 years.
Lead accumulates in bone during chronic exposure and
may be released when bone is reabsorbed during preg-
nancy or lactation (11,12). This release increases mater-
nal blood lead concentrations associated with fetal neuro-
logical damage (13,14).
Childhood lead poisoning prevention programs have var-
ious case management protocols for children with blood
lead concentrations of 10–19 µg/dL (0.48–0.96 µmol/L), but
the effect of these case management protocols on children’s
blood lead concentrations is unknown. We analyzed child-
hood blood lead surveillance data from six states to exam-
ine changes in blood lead concentrations among children
aged 2 years and younger to determine whether there was
any relationship with case management protocol. We
examined the following questions:
• Does blood lead concentration decline after an initial
venous blood lead test result of 10–19 µg/dL (0.48–0.96
µmol/L)?
• If so, is the size of the decline associated with state or
local case management protocol?
• Does the effect of the case management protocol differ if
the initial blood lead concentration is between 10–14
µg/dL (0.48–0.71 µmol/L) or between 15–19 µg/dL (0.72-
0.96 µmol/L)?
• Does the effect of case management protocol remain after
controlling for a child’s demographic characteristics?
Methods
We defined a case of borderline elevated blood lead con-
centration as a venous blood lead concentration of 10–19
µg/dL (0.48–0.96 µmol/L), regardless of the case definition
used by state and local lead poisoning prevention pro-
grams. The case management protocol for a state or coun-
ty was defined as the method of contact required under
the protocol (i.e., mail, telephone, or home visit) and the
type of service to be delivered under the protocol (i.e.,
educational materials on lead exposure prevention alone
or lead source investigation) for children with a given
blood lead concentration. Each child with blood lead con-
centrations of 10–19 µg/dL (0.48–0.96 µmol/L) was
assigned a method of contact and a type of service
according to information on case management protocol
provided by the coordinator of each state lead poisoning
prevention program. One state, Wisconsin, provided
county-level information. Children were assumed to
have received the services called for under the case man-
agement protocol of their state or county of residence.
Children’s demographic information and blood lead test
data came from CDC’s childhood blood lead database,
which is compiled from state childhood blood lead surveil-
lance data (15). Test results are submitted by laboratories
and physicians to state surveillance programs, which link
the laboratory tests of each child to ensure that duplicate
results are deleted and sequential tests are accurately
identified. We limited our analysis to six states that 1) had
laws requiring that the results of all blood lead tests on
children be reported to the state health department, 2)
submitted blood lead surveillance data from 1994 and 1995
to CDC, and 3) agreed to have their data used for our
analysis. These states were Iowa, Montana, New Mexico,
Ohio (only tests performed after April 1995, when univer-
sal reporting began, were included), Rhode Island, and
Wisconsin. 
In 1996, guidelines for blood lead screening changed.
Under the new guidelines, targeted screening of children
in high risk areas and populations was recommended
instead of universal screening — a change that altered the
population of children who were tested. We limited our
analysis to children who had an initial venous blood lead
test concentration of 10–19 µg/dL (0.48–0.96 µmol/L)
before they were aged 2 years and who had at least one fol-
low-up venous blood test 3 to 12 months after their initial
test. These parameters were selected to ensure sufficient
time for interventions to affect blood lead concentrations,
to examine the long-term effects of the interventions, and
to allow for varied case management protocols. Although a
follow-up test within this period was recommended for all
children with a venous blood lead concentration of 10–19
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µg/dL (0.48–0.96 µmol/L), the timing of the follow-up test
varied by case management protocol. The test could be
either a venous or a capillary test (7). We limited our
analysis to venous tests because greater variability in cap-
illary blood test results made it difficult to identify small
changes in blood lead levels. Among the six states, 121,862
children had a blood lead test result in the database, and
4606 (3.8%) children had an initial elevated level between
10–19 µg/dL (0.48–0.96 µmol/L) and at least one follow-up
test. Of these children, 2109 (46%) met our study criteria.
Our data set included all available test results as well as
demographic and intervention data for children who met
our study criteria.
We computed the change in blood lead concentration for
a child as the difference between the blood lead concentra-
tion at the first elevated venous test and the concentration
at the first venous follow-up test completed 3 to 12 months
after the initial elevated test. We calculated mean
changes as the average of individual changes for the group
and used paired t tests to test for significant changes. We
stratified our analysis by blood lead concentration because
we expected the magnitude of any decline in blood lead
concentration to be related to the initial concentration.
We used Kruskal-Wallis tests to compare mean changes
in blood lead concentrations, analysis of variance
(ANOVA) to compare the mean number of months needed
for blood lead concentrations to decline to less than 10
µg/dL (0.48 µmol/L), and the Mantel-Haenszel chi-square
test to determine differences in the proportion of children
whose blood lead concentration was less than 10 µg/dL
(0.48 µmol/L) at the end of follow-up. We examined the
relationship between case management protocol and
changes in blood lead concentration over the entire follow-
up period and controlled for the age of the child with gen-
eralized linear modeling. Quadratic splines with knots at
20, 50, and 80 percentiles for each variable allowed the
relationship between a child’s age at the initial test, or dur-
ing the time between tests, and blood lead concentration to
differ for different ages or time spans. All the venous blood
test results available for a child were used in generalized
equalizing equation modeling with autoregressive correla-
tion to examine the longitudinal relationship between case
management protocol and blood lead concentration. We
controlled for age at the initial and follow-up tests. We
used SAS Version 8 (SAS Institute, Inc, Cary, NC) for all
analyses (16).
Results
The children in this study were served by childhood lead
poisoning prevention programs that provided parental
education by mail (78%), telephone (21%), or home visits
(<1%) when a child’s blood lead concentration was 10–14
µg/dL (0.48–0.71 µmol/L). Forty-eight percent of children
in the study were served by childhood lead poisoning pre-
vention programs that also provided parental education by
mail when a child’s blood lead concentration was 15–19
µg/dL (0.72–0.96 µmol/L). The other 52% were covered by
childhood lead poisoning prevention programs that provid-
ed home visits. Eighty-four percent of the children were
covered by programs that provided education alone and
16% by programs that provided investigations of the
source of lead exposure (Table 1).
Forty percent of children in the study were aged 13
months and younger when they had their first elevated
blood lead test result (Table 1). A public agency paid for the
initial blood lead test of 33% of the children; 11% had pri-
vate payers, and payment source was unknown for 56%.
Race and ethnicity were known for 68% of the children. Of
all children in the study, 29% of the children were white,
21% were black, and 18% were Hispanic. Approximately
one half of the children were from Wisconsin. 
On average, blood lead concentrations increased by 0.25
µg/dL (0.01 µmol/L) between the first elevated venous
blood lead test and the first follow-up test done 3 to 12
months after the initial elevated test. The direction and
magnitude of change in blood lead concentration varied by
the child’s age at the initial elevated test, whether a public
or private entity paid for the test, the child’s race or eth-
nicity, and state of residence. Blood lead levels declined, on
average, among older children, those whose test was paid
for by private funds, those who were not white or Hispanic,
and residents of states other than Ohio and Wisconsin. The
sex of the child was not associated with changes in blood
lead concentrations (Table 1).
Overall, blood lead concentrations declined most among
children whose case management protocol called for a
home visit (Table 2). Blood lead concentrations decreased
by 1.96 µg/dL (0.09 µmol/L) in these children and by 0.72
µg/dL (0.03 µmol/L) among children in families receiving a
telephone call as follow-up. In contrast, blood lead concen-
trations increased 1.18 µg/dL (0.06 µmol/L) among chil-
dren receiving mail follow-up. Table 3 shows that blood
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lead concentrations declined by 0.92 µg/dL (0.04 µmol/L),
or  6%, on average among children covered by a protocol
that included a lead source investigation but rose by 0.36
µg/dL (0.02 µmol/L), or 4%, among children covered by pro-
tocols that provided only mailed educational materials.
The contrast between protocols was even more striking
for children whose initial blood lead concentration was
10–14 µg/dL (0.48–0.71 µmol/L). Table 2 shows that lead
concentrations rose by 1.49 µg/dL (0.07 µmol/L), 13.5%,
among children whose parents received mailed materials
but declined by 2.20 µg/dL (0.11 µmol/L), 18.8%, among
those who received a home visit. Also among children with
initial blood lead concentration of 10-14 µg/dL, lead source
investigation protocols were associated with an average
decline of 1.76 µg/dL (0.08 µmol/L) in lead concentration,
whereas education-only protocols were associated with an
average increase of 1.07 µg/dL (0.05 µmol/L) (Table 3).
The association with type of contact was less marked for
children whose initial blood lead concentration was 15–19
µg/dL (0.72–0.96 µmol/L), and there was no overall differ-
ence between blood lead concentrations among children
receiving mailed educational materials and those receiving
a lead source investigation (Table 3). Blood lead concen-
trations increased by 0.48 µg/dL (0.02 µmol/L) among chil-
dren who received mailed materials but declined by 1.95
µg/dL (0.09 µmol/L) among those who received home visits
(Table 2). Blood lead concentrations declined by 0.79 µg/dL
(0.04 µmol/L) among children who received mailed educa-
tional materials only and by 0.72 µg/dL (0.03 µmol/L)
among those who received a lead source investigation
(Table 3). The association between type of case manage-
ment protocol and changes in blood lead concentration per-
sisted even after we controlled for a child’s age at the first
elevated test result and follow-up tests (Tables 2,3). Blood
lead concentrations remained lower at the time of later
tests among children who received telephone contact or
home visits than among those contacted by mail (Table 2).
Concentrations also remained lower among those who
received a lead source investigation than among those who
received mailed educational materials only (Table 3). The
results were similar when the analysis was limited to chil-
dren aged 15 months or younger at the time of their initial
blood lead test (data not shown).
Among children with initial blood lead concentrations of
15–19 µg/dL (0.72–0.96 µmol/L) who received a home visit,
blood lead concentrations of those who received mailed
educational materials declined by 2.49 µg/dL (0.12
µmol/L), a larger decline than that of those who received
lead source investigations 0.72 µg/dL (0.03 µmol/L) (data
not shown). The difference remained after we adjusted for
a child’s age but was not significant at later tests.
We did not control for race, ethnicity, and payment
source in these models because of missing data; only 23%
of records included information on these variables. When
we fit models including race and payment source, we found
that home visits and lead source investigations among
children with initial blood lead concentrations of 10–14
µg/dL (0.48–0.71 µmol/L) were still associated with a sig-
nificant decline in blood lead concentrations between the
time of initial test and first follow-up test, but telephone
contact was not significant (data not shown). Including
these variables did not change any longitudinal effects sig-
nificantly.
Blood lead concentrations declined to less than 10 µg/dL
(0.48 µmol/L) by the last reported test among 43% of chil-
dren whose initial blood lead concentration was 10–14
µg/dL (0.48–0.71 µmol/L) and among 23% of children
whose initial blood lead concentration was 15–19 µg/dL
(0.72–0.96 µmol/L) (Table 4). On average, the time
required for blood lead concentrations to drop to less than
10 µg/dL (0.48 µmol/L) was 12 months for children with a
concentration of 10–14 µg/dL (0.48–0.71 µmol/L) and 13
months for those with an initial concentration of 15–19
µg/dL (0.72–0.96 µmol/L). Home visits were associated
with the highest proportion of children with blood lead con-
centrations of less than 10 µg/dL (0.48 µmol/L) by the last
reported follow-up test and with the shortest average time
required for blood lead concentrations to decline to less
than 10 µg/dL (0.48 µmol/L).
Discussion
We found that home visit protocols were associated
with a larger decline in blood lead concentrations than
mail or telephone contact protocols, regardless of a
child’s initial blood lead concentration. Mailed educa-
tional materials alone were not associated with lower
blood lead concentrations.
There are several possible limitations to our study. One
is that we may have underestimated the effects of case
management protocol. Another is that tested children may
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not have actually received the services called for by the
lead poisoning prevention program in their area. We also
had no information on the details of interventions and how
these may differ among programs. State laws require the
reporting of blood lead tests, but some results, especially
those below 10 µg/dL (0.48 µmol/L) or conducted by out-of-
state laboratories, may not have been reported or linked
to an appropriate child. We used the first venous test
performed at least 3 months after the index test of
10–19 µg/dL, but we included children who had at least
one follow-up test up to 12 months. Blood lead concen-
trations among children who had more time between the
initial test and the follow-up test would have more time to
decline, and this effect could bias our results. The analy-
ses that controlled for the timing of tests, however, should
not be affected by this limitation.
The effect of other limitations is less clear. We had no
information on many variables, such as iron or calcium
intake, that affect blood lead concentrations. Demographic
characteristics were missing for many children. We cannot
determine how results may have differed if we had been
able to control for race and payment source, but results of
analyses that included these variables were similar to ones
that did not. For these factors to affect our results, howev-
er, they would have to be associated with both the case
management protocol of the state or county childhood lead
poisoning prevention program and with changes in a
child’s blood lead concentration. Although many factors
are associated with an initial elevated blood lead concen-
tration, few have been found to affect changes in blood lead
concentration (16-20). Our study was limited to states that
require all blood lead test results be reported to the state
health department and may not apply to states not includ-
ed in the analysis.
Surveillance data result from tests performed at the
request of a child’s parents or physician, and circum-
stances for these children may differ from circumstances of
children who are not tested. This limitation may affect the
applicability of our findings to other children. Parents of
children who had an elevated blood lead test result but
who did not take their children for follow-up tests may be
less likely to implement measures to control lead exposure
than parents of children who did receive follow-up tests. If
this is true, we would expect all case management proto-
cols to be less effective in children overall than we found
among children in our study.
The total amount of lead stored in tissues in a child’s
body can affect blood lead concentrations and obscure the
efficacy of interventions. Lead is released during bone
turnover until all the stored lead has been released from
tissues. Rust et al estimated that among children aged 2
years and younger, bone lead stores could elevate blood
lead concentrations for up to 1 year after all sources of lead
exposure were removed (21). Bone lead stores could not be
estimated for children in this study and may have caused
us to underestimate the efficacy of all case management
protocols. Differences in bone lead stores, however,
could account for our results only if children who
received mail or education interventions had higher
bone lead stores on average than those of the same age
and initial blood lead concentration who received home
visits or lead source investigations.
Our study has several strengths in relation to other stud-
ies of interventions to reduce blood lead concentrations. We
had a large sample, which allowed us to detect small
effects on blood lead concentrations, and a diverse study
population in terms of race and ethnicity, population den-
sity, and geographic region. Our blood lead tests were
linked by child and allowed us to compare changes in an
individual’s blood lead concentration instead of an average
for a group.
We identified five randomized trial studies that exam-
ined the effectiveness of interventions to reduce blood lead
concentrations among children who had concentrations of
less than 20 µg/dL (0.97 µmol/L) (17,18,22,23). These inter-
ventions included professional house cleaning (17,22), pro-
vision of household cleaning supplies and instructions (23),
vacuuming with high efficiency particulate (HEPA) air fil-
ters (18), and provision of an individualized care plan that
included multiple home visits and parental teaching on
lead exposure prevention (24). Only one study intervention
was effective: repeated professional house cleaning result-
ed in a 2.1 µg/dL (0.1 µmol/L) decrease in blood lead con-
centration (22). In four of the studies, however, the controls
received a home visit that included information about pre-
vention of lead poisoning or identification of lead hazards;
this information was likely similar to information provided
by lead poisoning prevention programs (17,18,22,24). The
changes in mean blood lead concentration among these
control groups varied after 3 months: –5.9 µg/dL (–0.28
µmol/L) (17); –1.0 µg/dL (–0.05 µmol/L) (18), +0.1 µg/dL
(<0.01 µmol/L) (22), and –6.2 µg/dL (–0.3 µmol/L) (24).
Rhoads et al included information on accident prevention
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and provided safety equipment in addition to information
on lead hazards and lead poisoning prevention. The pres-
ence of safety and accident information may have lessened
the impact of the lead poisoning prevention information
(22). Hilts et al conducted their study near an active lead
smelter; this location increased the likelihood of lead expo-
sure. Aschengrau et al had only 24 children in randomized
groups and included older children whose blood lead levels
may already have begun to decline. The comparison group
in the study by Brown et al received one or two education-
al home visits. In the remaining study, controls received a
brochure on lead poisoning prevention (23). The blood lead
concentrations of these children declined slightly [0.60
µg/dL (0.03 µmol/L)], but the average age at recruitment
was 20 months, so the decline may be attributable to the
natural decline as children age.
All of these other studies measured the change in group
mean blood lead concentrations. We measured the change
in blood lead concentrations for individual children. The
decline in blood lead concentrations among children in our
study who received home visits [–1.96 µg/dL (0.09 µmol/L)],
however, was within the range of changes in blood lead
concentrations among these control groups.
Schultz et al, in a study of children followed by a local
lead poisoning prevention program, examined the average
changes in blood lead concentrations before and after the
program implemented home education visits among chil-
dren who had initial blood lead concentrations of 20–24
µg/dL (0.97–1.16 µmol/L) (25). These authors found that
blood lead concentrations declined by 3.9 µg/dL (0.19
µmol/L) on average among children who received home vis-
its but increased by 1.0 µg/dL (0.05 µmol/L) among chil-
dren who received no follow-up. They may have found a
larger decline in blood lead concentrations than we did
because the children in their study had higher initial blood
lead concentrations than those in our study.
The decline in blood lead concentrations among chil-
dren covered by a case management protocol that includ-
ed a home visit was larger and faster than predicted by
Neimuth and Schultz for children not receiving inter-
ventions (26). For children with the age and initial blood
lead concentration ranges of this study, Niemuth and
Schultz predicted changes at 12-month follow-up tests
that ranged from a 7% increase for children aged 6
months with an initial blood lead concentration of 10
µg/dL (0.48 µmol/L) to an 8.2% decrease for children
aged 24 months with an initial blood lead concentration
of 15 µg/dL (0.72 µmol/L) (26). We found a 19% decline
among children whose initial blood lead concentration
was 10–14 µg/dL (0.48–0.71 µmol/L) and who were cov-
ered by a case management protocol that included a
home visit and a 12% decline among those whose initial
blood lead concentration was 15–19 µg/dL (0.72–0.96
µmol/L). Mailed educational materials were associated
with a 10% increase in blood lead concentrations; this
increase was the same or higher than predicted for chil-
dren receiving no treatment.
Roberts et al estimated the time that would be required
for blood lead concentrations to decline to less than 10
µg/dL (0.48 µmol/L) among children who received no inter-
vention. In our study, the time required for initial blood
lead concentrations of 10–14 µg/dL (0.48–0.71 µmol/L) to
decline to less than 10 µg/dL (0.48 µmol/L) among children
covered by home visit protocols was similar to that esti-
mated by Roberts et al for children with blood lead con-
centrations in this range who received no intervention (27).
Among children whose initial blood lead concentration was
15–19 µg/dL (0.72–0.96 µmol/L) and who received a home
visit, however, blood lead concentrations declined to less
than 10 µg/dL (0.48 µmol/L) in 10 months — 4 months
faster than was estimated by Roberts et al (27).
Some clinicians have questioned the value of following
children with blood lead concentrations of less than 15
µg/dL (0.72 µmol/L) (28). Although a systematic evalua-
tion of the effect of different types of programs is needed,
our results suggest that blood lead concentrations of less
than 20 µg/dL (0.97 µmol/L) can be significantly reduced
with protocols that include home visits and lead source
investigations. This reduction is valuable because recent
research has suggested that even children with blood
lead concentrations of less than 10 µg/dL (0.48 µmol/L)
have identifiable cognitive deficits associated with lead
exposure because stored lead has long-term effects
(16,29). Other research has found that strong state poli-
cies requiring lead abatement in housing result in fewer
children exposed to lead and fewer children with elevat-
ed blood lead concentrations (30,31). Home investiga-
tions for children with borderline elevated blood lead
concentrations, combined with strong lead abatement
policies, could lower current and future lead exposure
among children.
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Tables
Table 1. Changes in Blood Lead Concentrations Between Initial Blood Lead Test and Follow-up Test by Demographic
Characteristics Among Children Aged 2 Years and Younger in Six U.S. States, 1994–1995
Total 2109 (100.0) 0.25 (0.2) .11 —
Age at first test, mo.
0-7 58 (2.8) 2.40 (1.1) .04 .005
8-10 246 (11.7) 1.34 (0.5) .009
11-13 540 (25.6) 0.53 (0.3) .12
14-16 431 (20.4) 0.14 (0.3) .67
17-19 395 (18.7) –0.39 (0.4) .27
20-24 439 (20.8) –0.29 (0.3) .38
Sex
Male 1054 (50.0) 0.32 (0.2) .16 .67
Female 937 (44.4) 0.16 (0.2) .51
Unknown 118 (5.6) 0.46 (0.7) .49
Payment source for laboratory test
Public 697 (33.0) 0.02 (0.3) .94 <.001
Private 225 (10.7) –1.31 (0.5) .005
Unknown 1187 (56.3) 0.69 (0.2) .001
Race and ethnicity
White 610 (28.9) 0.83 (0.3) .007 .02
Black 434 (20.6) –0.10 (0.3) .74
Native American 15 (0.7) –1.53 (1.7) .38
Hispanic 385 (18.3) 0.50 (0.4) .18
Other and unknown 665 (31.5) –0.14 (0.3) .65
State
Iowa 393 (18.6) 1.41 (0.3) <.001 <.001
Montana 33 (1.6) 3.03 (0.7) <.001
New Mexico 16 (0.8) 3.13 (1.2) .02
Ohio 224 (10.6) 0.34 (0.4) .43
Rhode Island 423 (20.0) 1.09 (0.4) .004
Wisconsin 1020 (48.4) 1.6 (0.2) <.001
aBlood lead concentrations are expressed in µg/dL. Conversion to SI µmol/L units is µg/dL × 0.0483 = µmol/L.
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Mean Changea t Test Kruskal-Wallis
Characteristics No. Children (%) (µg/dL) (SE) P Value P Value
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Table 2. Unadjusted and Adjusted Mean Changes in Blood Lead Concentration by Initial Level and Method of Family Contact
Among Children Aged 2 Years and Younger in Six U.S. States,a 1994–1995
Children with 2109 0.25 (0.2) .11 — — — —
initial blood lead 
concentration
10-19 µg/dL
Mail 1383 1.18 (0.2) <.001 Ref — Ref —
Telephone 262 –0.72 (0.02) .04 –1.95 (0.5) <.001 –0.80 (0.3) .01
Home visit 464 –1.96 (0.4) <.001 –2.98 (0.4) <.001 –2.00 (0.2) <.001
Children with 1233 0.99 (0.2) <.001 — — — —
initial blood lead 
concentration
10-14 µg/dL
Mail 961 1.49 (0.2) <.001 Ref — Ref —
Telephone 262 –0.72 (0.3) .04 –2.10 (0.5) <.001 –1.04 (0.3) <.001
Home 10 –2.20 (1.6) .20 –3.68 (2.2) .09 –0.86 (0.4) .04
Initial blood lead 876 –0.78 (0.3) .003 — — — —
concentration 
15-19 µg/dL
Mail 422 0.48 (0.4) .20 Ref — Ref —
Telephone 0 — — — — — —
Home 454 –1.95 (0.4) <.001 –2.50 (0.6) <.001 –1.87 (0.3) <.001
Ref indicates reference group.
aStates are Iowa, Montana, New Mexico, Ohio, Rhode Island, and Wisconsin.
bMean change in blood lead concentration between initial test and final follow-up test 3–12 months after initial test.
cMean change in blood lead concentration between initial test and first follow-up test 3–12 months after initial test, adjusted for child’s age.
dMean change in blood lead concentration over entire follow-up period, adjusted for child’s age at initial and follow-up testing.
eBlood lead concentrations are expressed in µg/dL. Conversion to SI µmol/L units is µg/dL × 0.0483 = µmol/L.
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Method of Mean Change Mean Change Mean Decline 
Contact for  Unadjusted for Ageb Adjusted for Agec Adjusted for Aged
All Children  
in Study No. Children µg/dLe (SE) t Test P Value µg/dL (SE) Wald P Value µg/dL (SE) Wald P Value
Table 3. Unadjusted and Adjusted Mean Changes in Blood Lead Concentration by Case Management Service Among Children
Aged 2 Years and Younger in Six U.S. States,a 1994–1995
Initial blood lead concentration 10-19 µg/dL
Education 1939 0.36 (0.2) .03 Ref — Ref —
Lead source 170 –0.92 (0.5) .06 –0.93 (0.6) .12 –0.89 (0.3) .001
investigation
Initial blood lead concentration 10-14 µg/dL
Education 1200 1.07 (0.2) <.001 Ref — Ref —
Lead source 33 –1.76 (0.7) .01 –2.59 (1.2) .03 –1.81 (0.4) <.001
investigation
Initial blood lead concentration 15-19 µg/dL
Education 739 –0.79 (0.3) .007 Ref — Ref —
Lead source 137 –0.72 (0.6) .22 0.24 (0.8) .75 –0.17 (0.3) .61 
investigation
Ref indicates reference group.
aStates are Iowa, Montana, New Mexico, Ohio, Rhode Island, and Wisconsin.
bMean change in blood lead concentration between initial test and final follow-up test 3–12 months after initial test.
cMean change in blood lead concentration between initial test and end of follow-up test period 3–12 months after initial test, adjusted for child’s age.
dMean change in blood lead concentration between initial test and end of follow-up, adjusted for child’s age at initial test.
eBlood lead concentrations are expressed in µg/dL. Conversion to SI µmol/L units is µg/dL × 0.0483 = µmol/L.
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Type of Mean Change Mean Change Mean Decline 
Service for  Unadjusted for Ageb Adjusted for Agec Adjusted for Aged
All Children  
in Study No. Children µg/dLe (SE) t Test P Value µg/dLe (SE) Wald P Value µg/dLe (SE) Wald P Value
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Table 4. Mean Number of Months Required to Reach Blood Lead Concentrations <10 µg/dL by End of Follow-up Period in Six
States,a 1994–1995
Initial blood lead 530 43.0 (1.4) 11.6 (9.9) — —
concentration
10-14 µg/dL (N = 1233)
Method of contact
Mail 353 36.7 (1.6) 12.3 (0.6) <.001 .06
Telephone 169 64.5 (3.0) 10.3 (0.6)
Home visit 8 80 (13.3) 8.9 (1.7)
Case management service
Mailed educational
materials 505 42.1 (1.4) 11.4 (0.4) .001 .04
Lead source investigation 25 75.8 (7.6) 15.6 (2.4)
Initial blood lead 205 23.4 (1.4) 12.7(0.8) — —
concentration
15-19 µg/dL
(N = 876)
Method of contact
Mail 67 15.9 (1.8) 18.2 (1.8) <.001 <.001
Telephone 0 NA NA
Home visit 138 30.4 (2.2) 10.0 (0.6)
Case management service
Education 184 24.9 (1.6) 13.4 (0.8) .02 .004
Lead source investigation 21 15.3 (3.1) 6.1 (0.9)
ANOVA indicates analysis of variance; NA, not applicable.
aStates are Iowa, Montana, New Mexico, Ohio, Rhode Island, and Wisconsin.
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No. Children Who % Children Who Mean No. Months to
Protocol Reached <10 µg/dL Reached <10 µg/dL (SE) reach <10 µg/dL (SE) X2 P Value ANOVA P Value
